EGA becomes Medicines for Europe
The organisation represents the generic, biosimilar and value added medicines industries across Europe
Medicines for Europe is the new name of the European Generic and Biosimilar medicines Association (EGA).
The industries represented by Medicines for Europe supply the majority of the regions prescription medicines, which is estimated to grow from the current 56% to 75% in volume over the next five years.
Medicines for Europe President Jacek Glinka explained that the repositioning 'reflects our industries’ purpose and strategic objectives. We have been through an incredible journey responding to the changes that have taken place in the pharmaceutical industry and European healthcare environment. I invite stakeholders and policy-makers to engage with us to deliver access to high quality medicines for all European patients.'
Medicines for Europe's members employ 160,000 people at more than 350 manufacturing and R&D sites in Europe, and invest up to 17% of their turnover in medical innovation.
